Literature DB >> 15550944

The life and times of ivermectin - a success story.

Satoshi Omura1, Andy Crump.   

Abstract

Since its introduction more than 20 years ago, ivermectin has proved to be one of the most successful therapeutic drugs in veterinary medicine, as well as the basis of one of the most successful public-health programmes of the past century. The drug arose from a unique international collaboration between the public and private sectors. The development process also incorporated the world's first and largest drug-donation programme and involved a unique association between governments, non-governmental organizations and industry. The drug is now being used, free of charge, in two global disease-elimination programmes that are benefiting millions of the world's poorest people.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15550944     DOI: 10.1038/nrmicro1048

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  66 in total

1.  Evaluation of the toxicity of 2-aminoimidazole antibiofilm agents using both cellular and model organism systems.

Authors:  Sean D Stowe; Ashley T Tucker; Richele Thompson; Amanda Piper; Justin J Richards; Steven A Rogers; Laura D Mathies; Christian Melander; John Cavanagh
Journal:  Drug Chem Toxicol       Date:  2012-01-31       Impact factor: 3.356

2.  Fate of ivermectin in the terrestrial and aquatic environment: mobility, degradation, and toxicity towards Daphnia similis.

Authors:  Susanne Rath; Leandro Alves Pereira; Sandra Maria Dal Bosco; Milena Guedes Maniero; Anne Hélène Fostier; José Roberto Guimarães
Journal:  Environ Sci Pollut Res Int       Date:  2015-11-18       Impact factor: 4.223

Review 3.  Taxonomy, Physiology, and Natural Products of Actinobacteria.

Authors:  Essaid Ait Barka; Parul Vatsa; Lisa Sanchez; Nathalie Gaveau-Vaillant; Cedric Jacquard; Jan P Meier-Kolthoff; Hans-Peter Klenk; Christophe Clément; Yder Ouhdouch; Gilles P van Wezel
Journal:  Microbiol Mol Biol Rev       Date:  2015-11-25       Impact factor: 11.056

Review 4.  Medicinal chemistry of adenosine, P2Y and P2X receptors.

Authors:  Kenneth A Jacobson; Christa E Müller
Journal:  Neuropharmacology       Date:  2015-12-12       Impact factor: 5.250

5.  The role of Brugia malayi ATP-binding cassette (ABC) transporters in potentiating drug sensitivity.

Authors:  Jeffrey B Tompkins; Laurel E Stitt; Alana M Morrissette; Bernadette F Ardelli
Journal:  Parasitol Res       Date:  2011-04-15       Impact factor: 2.289

6.  Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug.

Authors:  Mandy Juarez; Alejandro Schcolnik-Cabrera; Guadalupe Dominguez-Gomez; Alma Chavez-Blanco; Jose Diaz-Chavez; Alfonso Duenas-Gonzalez
Journal:  Cancer Chemother Pharmacol       Date:  2020-05-30       Impact factor: 3.333

Review 7.  Genomic basis for natural product biosynthetic diversity in the actinomycetes.

Authors:  Markus Nett; Haruo Ikeda; Bradley S Moore
Journal:  Nat Prod Rep       Date:  2009-09-01       Impact factor: 13.423

Review 8.  Familiar dermatologic drugs as therapies for COVID-19.

Authors:  M Ortega-Peña; R González-Cuevas
Journal:  Actas Dermosifiliogr       Date:  2020-12-23

9.  Glutamate-gated chloride channel subunit cDNA sequencing of Cochliomyia hominivorax (Diptera: Calliphoridae): cDNA variants and polymorphisms.

Authors:  Alberto Moura Mendes Lopes; Renato Assis de Carvalho; Ana Maria Lima de Azeredo-Espin
Journal:  Invert Neurosci       Date:  2014-06-15

Review 10.  Hit and lead criteria in drug discovery for infectious diseases of the developing world.

Authors:  Kei Katsuno; Jeremy N Burrows; Ken Duncan; Rob Hooft van Huijsduijnen; Takushi Kaneko; Kiyoshi Kita; Charles E Mowbray; Dennis Schmatz; Peter Warner; B T Slingsby
Journal:  Nat Rev Drug Discov       Date:  2015-10-05       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.